Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 2
2005 4
2006 5
2007 4
2008 5
2009 6
2010 4
2011 6
2012 7
2013 14
2014 17
2015 17
2016 15
2017 16
2018 24
2019 21
2020 14
2021 10
2022 11
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Cryocure-VT: the safety and effectiveness of ultra-low-temperature cryoablation of monomorphic ventricular tachycardia in patients with ischaemic and non-ischaemic cardiomyopathies.
Verma A, Essebag V, Neuzil P, Dyrda K, Balt J, Dinov B, Darma A, Arya A, Sacher F, Reddy VY, Boersma L, Grigorov I, De Potter T. Verma A, et al. Among authors: essebag v. Europace. 2024 Mar 30;26(4):euae076. doi: 10.1093/europace/euae076. Europace. 2024. PMID: 38582974 Free PMC article. Clinical Trial.
High-power short-duration versus low-power long-duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial.
Joza J, Nair GM, Birnie DH, Nery PB, Redpath CJ, Sarrazin JF, Champagne J, Bernick J, Wells GA, Essebag V; other members of the AWARE Study Consortium (Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence). Joza J, et al. Among authors: essebag v. J Cardiovasc Electrophysiol. 2024 Jan;35(1):136-145. doi: 10.1111/jce.16123. Epub 2023 Nov 21. J Cardiovasc Electrophysiol. 2024. PMID: 37990448 Clinical Trial.
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.
Wilkoff BL, Filippatos G, Leclercq C, Gold MR, Hersi AS, Kusano K, Mullens W, Felker GM, Kantipudi C, El-Chami MF, Essebag V, Pierre B, Philippon F, Perez-Gil F, Chung ES, Sotomonte J, Tung S, Singh B, Bozorgnia B, Goel S, Ebert HH, Varma N, Quan KJ, Salerno F, Gerritse B, van Wel J, Schaber DE, Fagan DH, Birnie D; AdaptResponse investigators. Wilkoff BL, et al. Among authors: essebag v. Lancet. 2023 Sep 30;402(10408):1147-1157. doi: 10.1016/S0140-6736(23)00912-1. Epub 2023 Aug 24. Lancet. 2023. PMID: 37634520 Clinical Trial.
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality.
Han HC, Wang J, Birnie DH, Alings M, Philippon F, Parkash R, Manlucu J, Angaran P, Rinne C, Coutu B, Low RA, Essebag V, Morillo C, Healey JS, Redfearn D, Toal S, Becker G, DeGrâce M, Thibault B, Crystal E, Tung S, LeMaitre J, Sultan O, Bennett M, Bashir J, Ayala-Paredes F, Gervais P, Rioux L, Hemels MEW, Bouwels LHR, Exner DV, Dorian P, Connolly SJ, Longtin Y, Krahn AD. Han HC, et al. Among authors: essebag v. JAMA Cardiol. 2023 May 1;8(5):484-491. doi: 10.1001/jamacardio.2023.0467. JAMA Cardiol. 2023. PMID: 37017943 Free PMC article.
185 results